Percheron Therapeutics LimitedASX: PER

MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK

Jun 27, 2023 at 10:07 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment